Earnings results for Teladoc Health (Searched 571 Times
Teladoc Health, Inc. is expected* to report earnings on 04/28/2021 after market close. The report will be for the fiscal Quarter ending Mar 2021. According to Zacks Investment Research, based on 10 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.59. The reported EPS for the same quarter last year was $-0.4.
Teladoc Health last posted its quarterly earnings data on February 24th, 2021. The health services provider reported ($3.07) EPS for the quarter, missing analysts’ consensus estimates of ($0.25) by $2.82. The company had revenue of $383.32 million for the quarter, compared to analyst estimates of $380.39 million. Teladoc Health has generated ($1.49) earnings per share over the last year. Teladoc Health has confirmed that its next quarterly earnings report will be published on Wednesday, April 28th, 2021.
Analyst Opinion on Teladoc Health (Searched 571 Times
32 Wall Street analysts have issued ratings and price targets for Teladoc Health in the last 12 months. Their average twelve-month price target is $242.75, predicting that the stock has a possible upside of 27.80%. The high price target for TDOC is $330.00 and the low price target for TDOC is $165.00. There are currently 13 hold ratings and 19 buy ratings for the stock, resulting in a consensus rating of “Buy.”
Teladoc Health has received a consensus rating of Buy. The company’s average rating score is 2.59, and is based on 19 buy ratings, 13 hold ratings, and no sell ratings. According to analysts’ consensus price target of $242.75, Teladoc Health has a forecasted upside of 27.8% from its current price of $189.95. Teladoc Health has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.
Dividend Strength: Teladoc Health (Searched 571 Times
Teladoc Health does not currently pay a dividend. Teladoc Health does not have a long track record of dividend growth.
Insiders buying/selling: Teladoc Health (Searched 571 Times
In the past three months, Teladoc Health insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $95,486,862.00 in company stock. Only 3.42% of the stock of Teladoc Health is held by insiders. 51.77% of the stock of Teladoc Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Earnings and Valuation of Teladoc Health (Searched 571 Times
Earnings for Teladoc Health are expected to grow in the coming year, from ($1.12) to ($0.60) per share. The P/E ratio of Teladoc Health is -132.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Teladoc Health is -132.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Teladoc Health has a P/B Ratio of 13.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
More latest stories: here